GABAPENTIN | A214956 | ASCENT PHARMACEUTICALS INC
Highest NADAC/Unit
$0.0428
per ea
Lowest NADAC/Unit
$0.0219
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722015001GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 31722015005GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 31722014901GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 31722014905GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 31722014805GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
| 31722014810GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
| 31722014801GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.